Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies.

Wei XuShenmiao YangConstantine S TamJohn F SeymourKeshu ZhouStephen OpatLugui QiuMingyuan SunTingyu WangJudith TrotmanLing PanSujun GaoJianfeng ZhouDaobin ZhouJun ZhuYuqin SongJianda HuRu FengHaiwen HuangDan SuMiao ShiJian-Yong Li

Published in: Advances in therapy (2022)

Clinical Trials.gov identifiers, NCT03189524, NCT02343120 (retrospectively registered), and NCT03206918 (retrospectively registered).

Keyphrases

chronic lymphocytic leukemia
clinical trial
diffuse large b cell lymphoma
acute lymphoblastic leukemia
acute myeloid leukemia
open label
multiple myeloma
hodgkin lymphoma
combination therapy
phase iii
phase ii
randomized controlled trial